Tatsuo Tanaka Selected Research

Adrenal Cortex Hormones (Corticosteroids)

1/2004

Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tatsuo Tanaka Research Topics

Disease

13	Neoplasms (Cancer) 01/2009 - 01/2002
10	Neoplasm Metastasis (Metastasis) 12/2008 - 01/2002
4	Colonic Neoplasms (Colon Cancer) 12/2008 - 01/2002
4	Ulcerative Colitis 06/2006 - 01/2004
4	Stomach Neoplasms (Stomach Cancer) 05/2004 - 01/2003
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 04/2011 - 10/2004
1	Alopecia (Baldness) 08/2012
1	Crohn Disease (Crohn's Disease) 08/2012
1	Cancer Pain 01/2012
1	Diamond-Blackfan Anemia (Anemia, Diamond Blackfan) 01/2006
1	Inflammation (Inflammations) 05/2005
1	Leiomyosarcoma 10/2004
1	Edema (Dropsy) 10/2004
1	Neutropenia 10/2004
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2004
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2004
1	Lymphatic Metastasis 03/2003
1	Fistula 01/2002
1	Duodenal Ulcer (Curling's Ulcer) 01/2002
1	Lymphoma (Lymphomas) 01/2002
1	Peptic Ulcer (Peptic Ulcers) 01/2002
1	Ulcer 01/2002

Drug/Important Bio-Agent (IBA)

3	Imatinib Mesylate (Gleevec)FDA Link 11/2007 - 08/2004
3	Proteins (Proteins, Gene)FDA Link 06/2003 - 01/2003
2	Angiogenesis InhibitorsIBA 01/2009 - 12/2008
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2009 - 12/2008
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2009 - 12/2008
2	Messenger RNA (mRNA)IBA 12/2008 - 06/2003
2	Interleukin-10 (Interleukin 10)IBA 06/2006 - 05/2005
2	CytokinesIBA 06/2006 - 05/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2003 - 01/2003
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 08/2012
1	N 30IBA 08/2012
1	Opioid Analgesics (Opioids)IBA 01/2012
1	Versicans (Versican)IBA 04/2011
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2009
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2009
1	Cytotoxins (Cytolysins)IBA 01/2009
1	Neutralizing AntibodiesIBA 12/2008
1	orantinib (SU6668)IBA 12/2008
1	Interleukin-12 (IL 12)IBA 12/2008
1	PropionatesIBA 12/2008
1	Chemokine CXCL1IBA 12/2008
1	PyrrolesIBA 12/2008
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 12/2008
1	Plasminogen Activator Inhibitor 2IBA 03/2008
1	Plasminogen Activators (Plasminogen Activator)IBA 03/2008
1	Plasminogen InactivatorsIBA 03/2008
1	Cyclin-Dependent Kinase Inhibitor p27IBA 12/2006
1	Interleukin-18 (Interleukin 18)IBA 06/2006
1	Interleukin-6 (Interleukin 6)IBA 06/2006
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 06/2006
1	VimentinIBA 02/2006
1	DesminIBA 02/2006
1	ribosomal protein S19IBA 01/2006
1	Oxygen (Dioxygen)IBA 05/2005
1	Tyrosine Kinase InhibitorsIBA 10/2004
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2004
1	Cisplatin (Platino)FDA LinkGeneric 05/2004
1	titanium silicide (TS-1)IBA 05/2004
1	Prednisolone (Predate)FDA LinkGeneric 01/2004
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2004
1	Therapeutic UsesIBA 11/2003
1	Photosensitizing Agents (Photosensitizers)IBA 11/2003
1	Dihematoporphyrin Ether (Porfimer Sodium)FDA Link 11/2003
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2003
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 06/2003
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2003
1	Plasminogen Activator Inhibitor 1IBA 01/2003
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2003
1	PlasminogenIBA 01/2003
1	Urokinase Plasminogen Activator ReceptorsIBA 01/2003
1	N-alpha-(4-(2-phenyl-2H- tetrazole-5-yl) phenyl sulfonyl)-D-tryptophanIBA 01/2002
1	Matrix Metalloproteinase InhibitorsIBA 01/2002

Therapy/Procedure

5	Gastrectomy 09/2006 - 01/2002
3	Therapeutics 08/2012 - 05/2004
3	Hepatectomy 11/2007 - 10/2004
1	Palliative Care (Palliative Therapy) 01/2012
1	Parenteral Infusions 03/2008
1	Neoadjuvant Therapy 08/2004
1	Drug Therapy (Chemotherapy) 05/2004
1	Blood Component Removal (Apheresis) 01/2004
1	Photochemotherapy (Photodynamic Therapy) 11/2003
1	Gastroenterostomy 01/2002
1	Pancreaticoduodenectomy 01/2002